返回 
加入收藏
产学研协同创新理论视角下医疗机构制剂平台建设新模式探索
x
请在关注微信后，向客服人员索取文件
| 篇名： | 产学研协同创新理论视角下医疗机构制剂平台建设新模式探索 |
| TITLE： | Exploration of a new model for the construction of medical institution formulation platforms from the perspective of industry-university-research collaborative innovation theory |
| 摘要： | 目的 探索医疗机构制剂平台建设模式，为促进医疗机构制剂发展提供思路。方法系统梳理我国医疗机构制剂的发展现状与挑战，基于产学研协同创新理论，确定平台组织架构、协同流程与保障机制。结果与结论我国医疗机构制剂主要面临研发能力薄弱、质量标准不均、转化渠道不畅等问题。本研究构建了覆盖政府、医疗机构、高校/科研院所、制药企业及市场的全链条、全产业协同创新链，形成“政产学研用”五位一体的医疗机构制剂平台建设新模式。该模式通过建立多主体协同合作、全链条知识产权管理、贡献导向型利益分配、分阶段风险共担及第三方评估等机制，明确各方权责与协同路径。该新模式突出临床经验方的全流程转化特色，实现临床需求与技术研发、制剂成果与产业转化的精准对接，在打破传统平台建设壁垒的同时，有助于优化资源配置、促进优势互补、解决医疗机构制剂发展中的关键问题，可为相关制度制定提供参考。 |
| ABSTRACT： | OBJECTIVE To explore a model for constructing a platform for medical institution formulation and provide insights for promoting their development. METHODS By systematically reviewing the development status and challenges of medical institution preparations in China， and based on the theory of industry-university-research collaborative innovation， the organizational structure， collaborative processes， and safeguard mechanisms of the platform were designed. RESULTS & CONCLUSIONS Medical institution formulations in China mainly faced challenges such as weak research and development （R&D） capacity， uneven quality standards， and blocked transformation pathways. This study established a full-chain， whole- industry collaborative innovation network covering the government， medical institutions， universities/research institutes， pharmaceutical enterprises， and the market， forming a new “government-industry-university-research-application” five-in-one platform model for medical institution formulations. By establishing mechanisms such as multi-entity collaborative cooperation， full- chain intellectual property management， contribution-based benefit distribution， staged risk-sharing， and third-party evaluation， the model clarified the responsibilities and collaborative pathways of all parties. The new model highlights the whole-process transformation of clinical experience-based prescriptions， enabling precise alignment between clinical needs and technological R&D， as well as between preparation achievements and industrial transformation. While breaking down the barriers of traditional platform construction， it effectively achieves optimal resource allocation and complementary advantages， addresses problems emerging in the development of medical institution preparations， and provides reference value for the formulation of relevant systems. |
| 期刊： | 2026年第37卷第02期 |
| 作者： | 林卡娜；沈安乐；王业健；王燕琼；李浩；郭艳芳；王有俊；孙心岩 |
| AUTHORS： | LIN Kana，SHEN Anle，WANG Yejian，WANG Yanqiong，LI Hao，GUO Yanfang，WANG Youjun，SUN Xinyan |
| 关键字： | 产学研协同创新；医疗机构制剂；平台建设；药学服务；成果转化 |
| KEYWORDS： | industry-university-research collaborative innova- |
| 阅读数： | 2 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
